Brentuximab-Induced Acute Interstitial Nephritis: A Case Report
Brentuximab vedotin is a combination monoclonal antibody to anti-CD30 conjugated to the anti-tubulin agent monomethyl auristatin E. It is approved for the treatment of mycosis fungoides, Hodgkin’s lymphoma, and systemic anaplastic large cell lymphoma. Brentuximab has been associated with a number of...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Canadian Journal of Kidney Health and Disease |
| Online Access: | https://doi.org/10.1177/20543581241300766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|